אליגרד 45 מג Israel - hebraico - Ministry of Health

אליגרד 45 מג

kamada ltd, israel - leuprorelin acetate - אבקה וממס להכנת תמיסה להזרקה - leuprorelin acetate 45 mg

אליגרד 45 מג Israel - hebraico - Ministry of Health

אליגרד 45 מג

kamada ltd, israel - leuprorelin acetate - אבקה וממס להכנת תמיסה להזרקה - leuprorelin acetate 45 mg

אליגרד 7.5 מג Israel - hebraico - Ministry of Health

אליגרד 7.5 מג

kamada ltd, israel - leuprorelin acetate - אבקה וממס להכנת תמיסה להזרקה - leuprorelin acetate 7.5 mg

אליגרד 7.5 מג Israel - hebraico - Ministry of Health

אליגרד 7.5 מג

kamada ltd, israel - leuprorelin acetate - אבקה וממס להכנת תמיסה להזרקה - leuprorelin acetate 7.5 mg

לוקרין פ.ד.ס דפו 3.75 מ"ג Israel - hebraico - Ministry of Health

לוקרין פ.ד.ס דפו 3.75 מ"ג

abbvie biopharmaceuticals ltd, israel - leuprorelin acetate 3.75 mg/vial - suspension for injection - leuprorelin - endometriosis prostatic cancer treatment of uterine fibroids for a period of up to six months. treatment of breast cancer in pre- and peri - menopausal women in whom hormone therapy is specified.

לוקרין פ.ד.ס דפו 11.25 מ"ג Israel - hebraico - Ministry of Health

לוקרין פ.ד.ס דפו 11.25 מ"ג

abbvie biopharmaceuticals ltd, israel - leuprorelin acetate 11.25 mg - powder for suspension for injection - leuprorelin - endometriosis prostatic cancer treatment of uterine fibroids for a period of up to six months. treatment of breast cancer in pre- and peri - menopausal women in whom hormone therapy is specified.

דלמרלין וטרינרי Israel - hebraico - Ministry of Health

דלמרלין וטרינרי

romat ltd - lecirelin 25 mcg/ml - solution for injection - cattle: treatment and prevention of follicular ovarian cysts - induction of cycling in cows showing irregular or prolonged cycles - short or silent heat - prolonged heat - ovulation synchronization at the time of insemination. horses: induction of ovulation. rabbits: induction of ovulation and conception rate enhancement.

בינוקריט 1000 יחבל 0.5 מל Israel - hebraico - Ministry of Health

בינוקריט 1000 יחבל 0.5 מל

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

בינוקריט 2000 יחבל 1 מל Israel - hebraico - Ministry of Health

בינוקריט 2000 יחבל 1 מל

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 2000 iu / 1 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

בינוקריט 30000 יחבל 0.75 מל Israel - hebraico - Ministry of Health

בינוקריט 30000 יחבל 0.75 מל

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 30000 iu / 0.75 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob